Ventripoint Diagnostics Ltd.

10:23 AM EST - Ventripoint Diagnostics Ltd. : Has completed a usability study for the VMS+ 3.0 system with very positive results.The study was completed in Toronto with clinicians from hospitals and cardiac clinics across Ontario. Participants found the system convenient and easy to use with 100% of the clinicians reporting that it was intuitive. One user noted "Exact ejection fraction values are helpful and critical for patient management" and another commented "the 3D view is the "wow" factor". Ventripoint Diagnostics Ltd. shares VPT are trading up $0.005 at $0.15.